arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

RIGEL PHARMACEUTICALS INC

RIGL

$40.12 ▲ +0.97 (+2.49%) at close

18 Visible periods

31 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Excellent

Bullish

auto_awesome

Analytical Summary

RIGEL PHARMACEUTICALS INC shows strong fundamentals with top-quartile Return on Common Equity (%) and Debt to Equity. The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $721.6M

Dividend Yield —

Revenue Growth 64.1% ↗

Op. Margin 42.6% ↗

ROIC 85.1% ↗

FCF / Share $4.21 ↗

Trailing P/E 2.0x

Price / Book 1.9x

FCF Yield 10.5%

Debt / Equity 0.13

info Valuation on last close. End-of-day price, Aug 7, 2026.

18-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$294.28M

↑ +64.1% —

Net Income Profit after all expenses

$367.02M

↑ +1999.1% —

Operating Margin Operating profit as % of sales

42.6%

↑ +215.9% 95th

FCF / Share Free cash flow per share

$4.21

↑ +134.9% —

Long-Term Debt Long-term obligations

$52.50M

↓ -12.5% —

trending_up

Bullish Indicators

Debt to EquityDebt to Equity is in the top quartile (lower is better)
Operating Margin (%)Operating Margin (%) is in the top quartile
Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

No bearish risks detected.

Health Breakdown

Profitability ↑

Returns

Financial Health ↓

Cash Quality

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Revenue Growth YoY (%)	64.1% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+702%)	53.4% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+567%)	-2.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-135%)	-19.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-343%)	37.4% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+367%)	83.2% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+940%)	33.2% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+315%)	892.6% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+11058%)	—	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	1960.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	58.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-209.1% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	38.9% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	2.9% Caution Caution Year-over-year change in earnings per share Optimal: > 10%	N/M	N/M	—	—
Net Income Growth YoY (%)	1999.1% Excellent ↑ Excellent Improving Year-over-year change in net income	N/M	57.2% Excellent ↑ Excellent Improving Year-over-year change in net income	-227.0% Weak ↓ Weak Declining Year-over-year change in net income	39.8% Excellent ↑ Excellent Improving Year-over-year change in net income	55.5% Excellent ↑ Excellent Improving Year-over-year change in net income	5.1% Fair ↑ Fair Improving Year-over-year change in net income	9.6% Fair ↑ Fair Improving Year-over-year change in net income	-12.7% Weak ↓ Weak Declining Year-over-year change in net income	-34.5% Weak ↓ Weak Declining Year-over-year change in net income	43.4% Excellent ↑ Excellent Improving Year-over-year change in net income	-2.1% Weak ↑ Weak Improving Year-over-year change in net income	9.9% Fair Fair Year-over-year change in net income	-15.0% Weak Weak Year-over-year change in net income	N/M	N/M	—	—
FCF Growth YoY (%)	134.9% Excellent Excellent Year-over-year change in free cash flow	N/M	92.3% Excellent Excellent Year-over-year change in free cash flow	N/M	N/M	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	34.8% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	6.3% Fair ↓ Fair Declining Compound annual revenue growth over 3 years	2.5% Caution ↓ Caution Declining Compound annual revenue growth over 3 years	26.6% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	49.7% Excellent Excellent Compound annual revenue growth over 3 years	189.3% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	22.1% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	24.8% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	21.3% Excellent Excellent Compound annual revenue growth over 5 years	93.1% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Operating Margin (%) (%)	42.6% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+184%)	13.5% Fair ↑ Fair Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-10%)	-17.5% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-217%)	-46.2% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-408%)	-8.4% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-156%)	-26.7% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-278%)	-116.5% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-877%)	-163.3% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1189%)	—	—	—	—	—	—	—	—	—	—
Effective Tax Rate (%) (%)	-201.3% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	4.8% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	-3.5% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	—	9.8% Caution ↑ Caution Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-19%)	-21.5% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-279%)	-48.7% Weak → Weak Stable Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-506%)	-12.0% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-200%)	-27.4% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-328%)	-112.8% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1040%)	-158.3% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1420%)	—	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	25.7% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	17.6% Good ↑ Good Improving Free cash flow as a percentage of revenue Optimal: > 10%	-4.9% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-61.7% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	3.5% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-49.2% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-72.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-134.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.21x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.80x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.23x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.27x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	-0.29x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.80x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.64x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.85x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.00x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.11x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Return on Invested Capital (%)	85.1% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	36.4% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-51.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-166.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-25.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-67.3% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-85.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-52.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-62.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-100.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-44.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-56.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-33.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-27.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-28.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	16.8% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	-80.6% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	24.4% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	14.8% Good ↑ Good Improving Operating profit relative to total assets Optimal: > 10%	-17.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-41.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-7.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-26.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-46.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-52.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-66.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-89.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-39.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-59.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-39.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-32.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-33.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	18.9% Excellent Excellent Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	93.8% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+525%)	—	87.6% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+484%)	—	-59.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-493%)	-87.4% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-683%)	-124.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-929%)	-64.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-528%)	-77.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-617%)	-125.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-939%)	-56.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-475%)	-70.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-573%)	-42.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-385%)	-34.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-328%)	-36.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-343%)	22.8% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+52%)	-101.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-777%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Debt to Equity (x)	0.13x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-78%)	18.25x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+2941%)	-2.09x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-449%)	-2.94x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-590%)	0.66x Fair Fair Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+10%)	—	0.19x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-69%)	—	—	—	—	—	—	—	—	—	—	—
Interest Coverage (x)	19.09x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	3.06x Fair ↑ Fair Improving Operating income divided by interest expense Optimal: > 5x	-2.98x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-14.99x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-2.57x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-21.41x Weak Weak Operating income divided by interest expense Optimal: > 5x	-206.24x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	-3454.72x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	388.10x Excellent Excellent Operating income divided by interest expense Optimal: > 5x	-551.91x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$11.92M	$3.25M	$27.21M	$15.54M	$1.11M	$-30.37M	$-12.52M	$-76.32M	$-38.29M	$-17.63M	$-43.46M	$-15.20M	$-20.85M	$-33.48M	$-18.63M	$-8.88M	$-14.72M	$-46.01M
Debt / EBITDA (x)	0.41x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	2.27x Fair ↑ Fair Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-3.12x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.73x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.76x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	-0.15x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Revenue per Share (USD)	$16.36	$10.20	$6.72	$6.97	$8.75	$6.44	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$20.40	$0.99	$-1.40	$-3.40	$-1.10	$-1.80	—	—	—	—	—	—	—	$-13.20	$-13.60	$7.30	$-27.30	—
Free Cash Flow per Share (USD)	$4.21	$1.79	$-0.33	$-4.30	$0.31	$-3.17	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$21.38	$0.19	$-1.64	$-0.79	$1.77	$2.01	$3.20	$6.57	$6.86	$5.54	$10.09	$14.57	$23.79	$33.18	$33.08	$31.78	$26.88	—
Tangible Book Value per Share (USD)	$21.38	$0.19	$-1.64	$-0.79	$1.77	$2.01	$3.20	$6.57	$6.86	$5.54	$10.09	$14.57	$23.79	$33.18	$33.08	$31.78	$26.88	—
Basic Weighted Avg Shares (shares)	17.99M	17.58M	17.40M	17.24M	17.05M	16.88M	—	—	—	—	—	8.77M	8.73M	7.50M	6.33M	5.21M	4.09M	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Working Capital (USD)	$140.93M	$71.80M	$46.00M	$50.69M	$90.91M	$48.14M	$60.79M	$109.25M	$99.10M	$53.63M	$95.23M	$136.51M	$209.78M	$290.25M	$238.71M	$168.60M	—	—
LT Debt (USD)	$52.50M	$60.00M	$60.00M	$40.00M	$20.00M	—	$10.00M	—	—	—	—	—	—	—	—	—	—	—
Total Equity (USD)	$391.48M	$3.29M	$-28.64M	$-13.62M	$30.37M	$34.03M	$53.81M	$109.88M	$100.65M	$55.03M	$91.38M	$128.25M	$208.25M	$289.10M	$236.15M	$166.13M	$109.87M	$104.17M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Sales/Revenue/Turnover (USD)	$294.28M	$179.28M	$116.88M	$120.24M	$149.24M	$108.62M	$59.29M	$44.51M	$4.48M	—	—	—	—	—	—	—	—	—
Depreciation Expense (USD)	$2.42M	$2.23M	$1.24M	$998.00K	$1.16M	$706.00K	$683.00K	$594.00K	$465.00K	$941.00K	$1.44M	$2.36M	$2.59M	$2.43M	$1.96M	$1.32M	$1.40M	—
Net Income, GAAP (USD)	$367.02M	$17.48M	$-25.09M	$-58.57M	$-17.91M	$-29.74M	$-66.89M	$-70.48M	$-77.99M	$-69.22M	$-51.46M	$-90.91M	$-89.03M	$-98.84M	$-85.97M	$37.89M	$-111.55M	—
Operating Cash Flow (USD)	$75.66M	$31.47M	$-5.74M	$-73.76M	$5.88M	$-52.19M	$-41.51M	$-58.83M	$-77.56M	$-75.89M	—	—	—	—	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 18 years · 67 quarters

RIGEL PHARMACEUTICALS INC

Analytical Summary

18-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare RIGL with peers